文献速递甲状腺疾病

甲状腺功能异常从妊娠早期持续至晚期的持续性研究

Persistency of Thyroid Dysfunction from Early to Late Pregnancy.
PubMed 文献 · Thyroid · 2019-08-28

本研究纳入42,492名未接受甲状腺治疗的孕妇,分析妊娠早期至晚期甲状腺功能异常的持续性。结果显示,未治疗的早期甲状腺疾病仅8.4-24.8%持续至晚三期,TPOAb阳性是持续性的主要预测因素,TPOAb阳性者亚临床甲减或低甲状腺素血症持续风险较低,但(亚临床)甲亢持续风险较高。

要点

  • 未治疗的早期妊娠甲状腺疾病仅少数持续至晚三期。
  • TPOAb阳性是甲状腺功能异常持续的主要预测因素。
  • 诊断时TSH低于约5 mU/L的亚临床甲减持续风险可降低达50%。

核心结论

  • 未治疗的早期妊娠甲状腺疾病仅8.4-24.8%持续至晚三期。
  • TPOAb阳性是持续性的主要预测因素。

研究设计与样本

  • 研究纳入42,492名在妊娠前或妊娠期间未接受甲状腺治疗的孕妇,具备早孕期和晚孕期TSH、fT4、T3或TPOAbs数据。
  • 分析调整了母亲年龄、产次、人体测量学和β-hCG浓度等潜在混杂因素。

主要发现

  • 亚临床甲减和低甲状腺素血症持续比例分别为24.8%和17.7%。
  • 临床甲亢持续比例为8.4%,亚临床甲亢持续比例为20.9%。
  • 低T3持续比例为43.4%,高T3持续比例为15.7%。
  • TPOAb阳性持续比例为84.0%。
  • 亚临床甲减女性诊断时TSH低于约5 mU/L与持续性风险降低达50%相关。

关键数值与推荐

  • 诊断时fT4浓度预测甲亢持续性。
  • TPOAb阳性预测所有疾病实体的持续性。
  • TPOAb阳性女性亚临床甲减或低甲状腺素血症持续风险较低,但(亚临床)甲亢持续风险较高。

临床怎么用

  • 对妊娠早期甲状腺疾病患者,应评估TPOAb状态以预测持续性风险。
  • 亚临床甲减患者诊断时TSH低于约5 mU/L者持续风险较低,可考虑更密切监测或个体化管理。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background: Subclinical thyroid disease occurs in approximately 5-8% of all pregnancies and is associated with a higher risk of adverse outcomes such as miscarriage, preterm birth, and suboptimal child neurodevelopment. It is generally assumed that subclinical thyroid disease that persists from early to late pregnancy is associated with a higher risk of adverse outcomes than transient disease. However, it is unknown as to what percentage of women with subclinical disease during early pregnancy have persistent disease in the third trimester. Methods: This study comprised 42,492 mothers for whom early and late pregnancy thyrotropin (TSH), free thyroxine (fT4), triiodothyronine (T3), or TPOAbs were available and who did not receive thyroid treatment before or during pregnancy. We adjusted for potential confounders, including maternal age, parity, anthropometrics, and β-hCG concentrations. Results: Subclinical hypothyroidism and hypothyroxinemia persisted in 24.8% and 17.7% of cases. Overt hyperthyroidism persisted in 8.4% of cases while subclinical hyperthyroidism persisted in 20.9% of cases. Low T3 persisted in 43.4% of cases while elevated T3 persisted in 15.7% of cases. TPOAb positivity persisted in 84.0% of cases. In women with subclinical hypothyroidism, a TSH below ∼5 mU/L at the time of diagnosis was associated with an up to 50% lower risk of persistency. The fT4 concentration at diagnosis predicted hyperthyroidism persistency and TPOAb positivity predicted persistency of all disease entities. Conclusions: Early pregnancy thyroid disease only persists until the third trimester in 8.4-24.8% of cases when left untreated. The main predictor for persistency is TPOAb positivity, with TPOAb-positive women having a lower risk that subclinical hypothyroidism or hypothyroxinemia persists, but a higher risk that (subclinical) hyperthyroidism persists.

来源:Thyroid,查看原文。版权归原作者所有。

引用

  1. Fan J, Zhang Y, Zhang C, et al. Persistency of Thyroid Dysfunction from Early to Late Pregnancy. Thyroid. 2019. PMID: 31347461. doi:10.1089/thy.2019.0115

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。